Background. Animal-assisted interventions (AAI), the use of animals as a complementary therapy in holistic patient care, has shown many positive outcomes. However, therapy animals can serve as mechanical vectors of hospital-associated infections (HAI), e.g., methicillin-resistant Staphylococcus aureus (MRSA). This pilot study assessed for transmission of HAIs among therapy animals, patients, and the hospital environment. We tested the effectiveness of a novel decolonization protocol for therapy dogs to reduce the risk of transmission of HAIs and enhance AAI program sustainability. Our hypothesis was that HAI transmission occurs from positive child to child, with the dog as an intermediary fomite.
Prevalence and Risk Factors for Candida auris
Background. Candida auris can be transmitted in healthcare settings, and patients can become asymptomatically colonized, increasing risk for invasive infection and transmission. We investigated an ongoing C. auris outbreak at a 30-bed long-term acute care hospital to identify colonization for C. auris prevalence and risk factors.
Methods. During February-June 2017, we conducted point prevalence surveys every 2 weeks among admitted patients. We abstracted clinical information from medical records and collected axillary and groin swabs. Swabs were tested for C. auris. Data were analyzed to identify risk factors for colonization with C. auris by evaluating differences between colonized and noncolonized patients.
Results. All 101 hospitalized patients were surveyed, and 33 (33%) were colonized with C. auris. Prevalence of colonization ranged from 8% to 38%; incidence ranged from 5% to 20% (figure). Among colonized patients with available data, 19/27 (70%) had a tracheostomy, 20/31 (65%) had gastrostomy tubes, 24/33 (73%) ventilator use, and 12/27 (44%) had hemodialysis. Also, 31/33 (94%) had antibiotics and 13/33 (34%) antifungals during hospitalization. BMI for colonized patients (mean = 30.3, standard deviation (SD) = 10) was higher than for noncolonized patients (mean = 26.5, SD = 7.9); t = −2.1; P = 0.04). Odds of colonization were higher among Black patients (33%) vs. White patients (16%) (odds ratio [OR] 3.5; 95% confidence interval [CI] 1.3-9.8), and those colonized with other multidrug-resistant organism (MDRO) (72%) vs. noncolonized (44%) (OR 3.2; CI 1.3-8.0). Odds of death were higher among colonized patients (OR 4.6; CI 1.6-13.6).
Conclusion. Patients in long-term acute care facilities and having high prevalences of MDROs might be at risk for C. auris. Such patients with these risk factors could be targeted for enhanced surveillance to facilitate early detection of C. auris. Infection control measures to reduce MDROs' spread, including hand hygiene, contact precautions, and judicious use of antimicrobials, could prevent further C. auris transmission.
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The authors thank Janet Glowicz and Kathleen Ross. exposure on or prior to the MDRO culture collection date in cases or during the entire hospitalization in controls. The association between antibiotics and MDRO detection was assessed with χ 2 and multivariable logistic regression testing. Length of stay (LOS) was compared between groups.
Results. Of 1,181 advanced cancer patients started on palliative chemotherapy and subsequently admitted, we identified 45 cases and 135 controls (figure). Overall, median age was 75 years (range 65-95) and 48% (N = 87/180) were female. Antibiotic exposure was more likely in cases (91%, N = 41/45) vs. controls (75%, N = 101/135; P = 0.02). In regression testing adjusted for gender, LOS, and ICU stay, antibiotic use was associated with MDRO detection (OR = 3.23, 95% CI 1.1, 9.8; P = 0.04). Mean LOS was higher in those with (8.7 days, 95% CI 7.5, 10.0) vs. without (3.5 days, 95% CI 3.8, 6.1) MDRO detection (P = 0.002) Conclusion. In older advanced cancer patients on palliative chemotherapy, antibiotic use is predictive of new MDRO detection, and patients with new MDRO detection have significantly longer LOS. These results suggest antibiotics should be used cautiously in palliative care patients in whom the burdens of MDRO detection, such as longer LOS and potential room isolation with contact precautions, may conflict with goals of care. 
